SANDOZ LOSARTAN DIN 02313332

Status: Marketed

Holder: SANDOZ CANADA INCORPORATED

Available to quote

Health Canada record

Active ingredient(s)	LOSARTAN POTASSIUM 25 MG
Dosage form	Tablet
Route	Oral
Schedule	PRESCRIPTION
Class	Human
ATC	C09CA01 LOSARTAN
Original market date	25-Jan-2012
Current status date	25-Jan-2012
Source	Health Canada DPD

Establishment licence of the holder

Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).

Canadian shortage reports

Status	Reason	Updated
resolved	25MG	2026-09-04
resolved	50MG	2026-09-04
active	100MG 12.5MG	2026-09-04

Other Canadian products containing LOSARTAN POTASSIUM

DIN	Product	Company	Form	Strength	Status
02182874	COZAAR	ORGANON CANADA INC.	Tablet	LOSARTAN POTASSIUM 50 MG	Marketed
02182815	COZAAR	ORGANON CANADA INC.	Tablet	LOSARTAN POTASSIUM 25 MG	Marketed
02182882	COZAAR	ORGANON CANADA INC.	Tablet	LOSARTAN POTASSIUM 100 MG	Marketed
02230047	HYZAAR	ORGANON CANADA INC.	Tablet	LOSARTAN POTASSIUM 50 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Marketed
02297841	HYZAAR	ORGANON CANADA INC.	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Marketed
02241007	HYZAAR DS	ORGANON CANADA INC.	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 25 MG	Marketed
02388812	LOSARTAN	SIVEM PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 100 MG	Marketed
02388804	LOSARTAN	SIVEM PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 50 MG	Marketed
02388790	LOSARTAN	SIVEM PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 25 MG	Marketed
02388898	LOSARTAN	SANIS HEALTH INC	Tablet	LOSARTAN POTASSIUM 100 MG	Marketed
02388871	LOSARTAN	SANIS HEALTH INC	Tablet	LOSARTAN POTASSIUM 50 MG	Marketed
02388863	LOSARTAN	SANIS HEALTH INC	Tablet	LOSARTAN POTASSIUM 25 MG	Marketed
02388979	LOSARTAN HCT	SIVEM PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Marketed
02388960	LOSARTAN HCT	SIVEM PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 50 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Marketed
02388987	LOSARTAN HCT DS	SIVEM PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 25 MG	Marketed
02389665	MINT-LOSARTAN/HCTZ	MINT PHARMACEUTICALS INC	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Marketed
02389657	MINT-LOSARTAN/HCTZ	MINT PHARMACEUTICALS INC	Tablet	LOSARTAN POTASSIUM 50 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Marketed
02389673	MINT-LOSARTAN/HCTZ DS	MINT PHARMACEUTICALS INC	Tablet	LOSARTAN POTASSIUM 100.0 MG; HYDROCHLOROTHIAZIDE 25.0 MG	Marketed
02309769	PMS-LOSARTAN	PHARMASCIENCE INC	Tablet	LOSARTAN POTASSIUM 50 MG	Marketed
02309750	PMS-LOSARTAN	PHARMASCIENCE INC	Tablet	LOSARTAN POTASSIUM 25 MG	Marketed
02309777	PMS-LOSARTAN	PHARMASCIENCE INC	Tablet	LOSARTAN POTASSIUM 100 MG	Marketed
02392240	PMS-LOSARTAN-HCTZ	PHARMASCIENCE INC	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 25 MG	Marketed
02392224	PMS-LOSARTAN-HCTZ	PHARMASCIENCE INC	Tablet	LOSARTAN POTASSIUM 50 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Marketed
02392232	PMS-LOSARTAN-HCTZ	PHARMASCIENCE INC	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Marketed
02313340	SANDOZ LOSARTAN	SANDOZ CANADA INCORPORATED	Tablet	LOSARTAN POTASSIUM 50 MG	Marketed
02313359	SANDOZ LOSARTAN	SANDOZ CANADA INCORPORATED	Tablet	LOSARTAN POTASSIUM 100 MG	Marketed
02362449	SANDOZ LOSARTAN HCT	SANDOZ CANADA INCORPORATED	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Marketed
02313375	SANDOZ LOSARTAN HCT	SANDOZ CANADA INCORPORATED	Tablet	LOSARTAN POTASSIUM 50 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Marketed
02313383	SANDOZ LOSARTAN HCT DS	SANDOZ CANADA INCORPORATED	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 25 MG	Marketed
02357968	TEVA-LOSARTAN	TEVA CANADA LIMITED	Tablet	LOSARTAN POTASSIUM 50 MG	Marketed
02380838	TEVA-LOSARTAN	TEVA CANADA LIMITED	Tablet	LOSARTAN POTASSIUM 25 MG	Marketed
02357976	TEVA-LOSARTAN	TEVA CANADA LIMITED	Tablet	LOSARTAN POTASSIUM 100 MG	Marketed
02354829	ACT LOSARTAN	ACTAVIS PHARMA COMPANY	Tablet	LOSARTAN POTASSIUM 25 MG	Cancelled Post Market
02354837	ACT LOSARTAN	ACTAVIS PHARMA COMPANY	Tablet	LOSARTAN POTASSIUM 50 MG	Cancelled Post Market
02354845	ACT LOSARTAN	ACTAVIS PHARMA COMPANY	Tablet	LOSARTAN POTASSIUM 100 MG	Cancelled Post Market
02388286	ACT LOSARTAN/HCT	ACTAVIS PHARMA COMPANY	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 25 MG	Cancelled Post Market
02388251	ACT LOSARTAN/HCT	ACTAVIS PHARMA COMPANY	Tablet	LOSARTAN POTASSIUM 50 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Cancelled Post Market
02388278	ACT LOSARTAN/HCT	ACTAVIS PHARMA COMPANY	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Cancelled Post Market
02353504	APO-LOSARTAN	APOTEX INC	Tablet	LOSARTAN POTASSIUM 50 MG	Dormant
02353512	APO-LOSARTAN	APOTEX INC	Tablet	LOSARTAN POTASSIUM 100 MG	Dormant
02379058	APO-LOSARTAN	APOTEX INC	Tablet	LOSARTAN POTASSIUM 25 MG	Cancelled Post Market
02371251	APO-LOSARTAN/HCTZ	APOTEX INC	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 25 MG	Cancelled Post Market
02371235	APO-LOSARTAN/HCTZ	APOTEX INC	Tablet	LOSARTAN POTASSIUM 50 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Cancelled Post Market
02371243	APO-LOSARTAN/HCTZ	APOTEX INC	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Cancelled Post Market
02314495	DOM-LOSARTAN	DOMINION PHARMACAL	Tablet	LOSARTAN POTASSIUM 100 MG	Cancelled Pre Market
02314487	DOM-LOSARTAN	DOMINION PHARMACAL	Tablet	LOSARTAN POTASSIUM 50 MG	Cancelled Pre Market
02314479	DOM-LOSARTAN	DOMINION PHARMACAL	Tablet	LOSARTAN POTASSIUM 25 MG	Cancelled Pre Market
02368285	MYLAN-LOSARTAN	MYLAN PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 50 MG	Cancelled Post Market
02368293	MYLAN-LOSARTAN	MYLAN PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 100 MG	Cancelled Post Market
02368277	MYLAN-LOSARTAN	MYLAN PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 25 MG	Cancelled Post Market
02378078	MYLAN-LOSARTAN HCTZ	MYLAN PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 50 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Cancelled Post Market
02378094	MYLAN-LOSARTAN HCTZ	MYLAN PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 25 MG	Cancelled Post Market
02378086	MYLAN-LOSARTAN HCTZ	MYLAN PHARMACEUTICALS ULC	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Cancelled Post Market
02314460	PHL-LOSARTAN	PHARMEL INC	Tablet	LOSARTAN POTASSIUM 100 MG	Cancelled Pre Market
02314452	PHL-LOSARTAN	PHARMEL INC	Tablet	LOSARTAN POTASSIUM 50 MG	Cancelled Pre Market
02314444	PHL-LOSARTAN	PHARMEL INC	Tablet	LOSARTAN POTASSIUM 25 MG	Cancelled Pre Market
02358271	RATIO-LOSARTAN HCTZ	TEVA CANADA LIMITED	Tablet	LOSARTAN POTASSIUM 100.0 MG; HYDROCHLOROTHIAZIDE 25.0 MG	Cancelled Pre Market
02358263	TEVA-LOSARTAN/HCTZ	TEVA CANADA LIMITED	Tablet	LOSARTAN POTASSIUM 50.0 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Cancelled Post Market
02377152	TEVA-LOSARTAN/HCTZ	TEVA CANADA LIMITED	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 25 MG	Cancelled Post Market
02377144	TEVA-LOSARTAN/HCTZ	TEVA CANADA LIMITED	Tablet	LOSARTAN POTASSIUM 100 MG; HYDROCHLOROTHIAZIDE 12.5 MG	Cancelled Post Market

Notices of Compliance

NOC	Date	Submission	Reason
12953	2012-01-25	Abbreviated New Drug Submission (ANDS)

International API supply for LOSARTAN POTASSIUM

17 valid EDQM Certificates of Suitability from 16 holders. 31 active FDA Drug Master Files.

Request a quote for SANDOZ LOSARTAN

How to read a Canadian DIN record